ArticlePharmaceutics2026

Cross-Species Hepatic Metabolism of the Antileishmanial Chalcone NAT22 Generates Metabolites with Predicted Enhanced Affinity for the Parasite Target cTXNPx.

Arielly R R Barreto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.